Novartis India Ltd
NSE:NOVARTIND
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
|
Novartis India Ltd
NSE:NOVARTIND
|
16.6B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
295.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.1B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
248.2B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
309B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.4B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.1B USD |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Novartis India Ltd
Glance View
Novartis India Ltd. engages in developing and marketing transformative treatments for people in areas of medical need. The company is headquartered in Mumbai, Maharashtra and currently employs 81 full-time employees. The firm focuses on over three divisions, including pharmaceuticals, eye care and generic medicines. In India, its pharmaceutical business is focused on bone and pain, calcium portfolio, gynecology and neurosciences, and the generics business is focused on gynecology, anti-tuberculosis (TB) and anti-infectives. The company focuses on therapeutic areas, such as cardiovascular, renal and metabolism, immunology and dermatology, ophthalmology, neuroscience and respiratory. The company develops gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The company is developing a chimeric antigen receptor (CAR)-T platform for various investigational CAR-T therapies in its pipeline. The firm has presence in various locations in India, including Delhi, Bengaluru, Kolkata, Chennai and Lucknow.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Novartis India Ltd is 14%, which is below its 3-year median of 14.2%.
Over the last 3 years, Novartis India Ltd’s Operating Margin has increased from 5.4% to 14%. During this period, it reached a low of -1.6% on Jun 30, 2022 and a high of 15.9% on Mar 31, 2023.
